for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

EU regulator says no clot risk factor yet linked to AstraZeneca vaccine

March 31 (Reuters) - Europe’s medicines regulator said on Wednesday it had not yet identified any risk factors such as age, sex or a previous history of blood clotting disorders, for clotting cases reported after inoculation with AstraZeneca’s COVID-19 vaccine.

The vaccine’s benefits outweigh the risks, the European Medicines Agency reiterated, but cautioned that people should be aware of the remote possibility of rare blood clots occurring, and must seek immediate medical attention in case of symptoms. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up